MedTrace Logo

Adding Desmopressin to Tamsulosin for Treatment of BPH

NCT05945420 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2023-07-14

No results posted yet for this study

Summary

In this study investigators will add desmopressin for treatment of patients with benign prostatic hyperplasia and nocturnal polyurea

Conditions

  • Nocturnal Polyurea in Patients With BPH

Interventions

DRUG

Desmopressin Acetate

This arm will receive tamsulosin and desmopressin acetate daily a

DRUG

Placebo

This arm will receive tamsulosin and placebo

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-20
Primary Completion
2024-01-10
Completion
2024-02-10

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05945420 on ClinicalTrials.gov